BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 37576886)

  • 1. The risk of acute pancreatitis associated with acid-suppressing drugs.
    Eland IA; Alvarez CH; Stricker BH; Rodríguez LA
    Br J Clin Pharmacol; 2000 May; 49(5):473-8. PubMed ID: 10792205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Migraine and Gastrointestinal Disease in Pediatric Patients: A Propensity Score Weighting Approach.
    Rhew K
    Neuropsychiatr Dis Treat; 2023; 19():2607-2615. PubMed ID: 38046830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association between Ranitidine Use and Gastrointestinal Cancers.
    McGwin G
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile Acid Diarrhea is Associated with an Increased Incidence of Gastrointestinal Cancers.
    Ellegaard AM; Kårhus ML; Winther-Jensen M; Knop FK; Kårhus LL
    Am J Gastroenterol; 2024 May; ():. PubMed ID: 38717021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of oseltamivir on the risk of cancer.
    Chuang PH; Tzang BS; Tzang CC; Chiu CC; Lin CY; Hsu TC
    Front Oncol; 2024; 14():1329986. PubMed ID: 38469236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ranitidine and nizatidine on the risk of gastrointestinal cancer.
    Kang H; Nam CM; Choi DW; Park S
    Front Oncol; 2023; 13():1182174. PubMed ID: 37576886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018.
    Iwagami M; Kumazawa R; Miyamoto Y; Ito Y; Ishimaru M; Morita K; Hamada S; Tamiya N; Yasunaga H
    Drug Saf; 2021 Mar; 44(3):361-371. PubMed ID: 33247391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S; Holtmann G
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
    Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H
    Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study.
    Di Mario F; Battaglia G; Naccarato R; D'Angelo A; Saggioro A; Da Broi GL; Vezzadini P; Bianchi Porro G
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():62-5. PubMed ID: 1982108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nizatidine versus ranitidine on gastric intraluminal prostaglandin release in duodenal ulcer patients.
    Silecchia G; Spaziani E; Guarino E; Neri T; Grasso E; Mariani P; Materia A; Genco A; Basso N
    Scand J Gastroenterol Suppl; 1994; 206():8-13. PubMed ID: 7863255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association between Hypertriglyceridemia and Colorectal Cancer: A Long-Term Community Cohort Study in Taiwan.
    Hsu SH; Syu DK; Chen YC; Liu CK; Sun CA; Chen M
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine Use and Risk of Upper Gastrointestinal Cancers.
    Adami HO; Trolle Andersen I; Heide-Jørgensen U; Chang ET; Nørgaard M; Sørensen HT
    Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2302-2308. PubMed ID: 34620629
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.